Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nintedanib in post-COVID-19 lung fibrosis
TCTR20220426001Not yet recruiting
- Sponsor
- Thammasat University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nintedanib in pulmonary fibrosis (PF), sponsored by Thammasat University. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
nintedanib
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on TCTR20220426001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220426001.